Profiles: Page 5

The latest opinion pieces by industry thought leaders

  • A portrait of Andrew Miller framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Andrew Miller
    Image attribution tooltip

    Entrepreneurs: Andrew Miller

    The founder and COO of Karuna Therapeutics is leveraging a combination of persistence and adaptability to scale up the biopharmaceutical company.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Ann Barnes framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ann Barnes
    Image attribution tooltip

    DE&I Champions: Ann Barnes

    The CEO of Intelligent Medical Objects is growing her company’s diversity initiatives — and its bottom line.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Armon Sharei framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Armon Sharei
    Image attribution tooltip

    Entrepreneurs: Armon Sharei

    The CEO of SQZ Biotech is leveraging a technology platform that is simple in its design yet targeted at making cell therapy to break down barriers to the treatments.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Baba Shetty framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Baba Shetty
    Image attribution tooltip

    Tech Wizards: Baba Shetty

    The pragmatic president of technology and data solutions at Syneos Health helps healthcare companies do what they imagine.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Barbara Klencke framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Barbara Klencke
    Image attribution tooltip

    Innovators: Dr. Barbara Klencke

    The chief medical officer at Sierra Oncology, a GSK company, is working to make high-impact changes for rare cancer patients.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dr. Barbara Wirostko framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Barbara Wirostko
    Image attribution tooltip

    Entrepreneurs: Dr. Barbara Wirostko

    Qlaris Bio’s CMO and co-founder has her sights on bringing life-changing treatments to patients with debilitating eye diseases.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Ben Yerxa framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ben Yerxa
    Image attribution tooltip

    Entrepreneurs: Ben Yerxa

    The CEO in retinal diseases sees opportunities for drug development success by merging the work of a gene therapy startup with venture philanthropy.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Jonathan Steckbeck framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jonathan Steckbeck
    Image attribution tooltip

    Disrupters: Jonathan Steckbeck

    The CEO, founder and president of Peptilogics is changing the game for the peptide medicine space with a promising pipeline and a disruptive discovery platform.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Beth Crouse framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Beth Crouse
    Image attribution tooltip

    Entrepreneurs: Beth Crouse

    The 2nd Spark CEO is on a mission to create ‘brand fans’ and bring meaningful marketing experiences to healthcare.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Bobak Azamian framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Bobak Azamian
    Image attribution tooltip

    Entrepreneurs: Dr. Bobak Azamian

    The CEO is bringing his vision for innovative eye therapies to Tarsus Pharmaceuticals.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dr. Jordan Schecter framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jordan Schecter
    Image attribution tooltip

    Innovators: Dr. Jordan Schecter

    The VP of cellular therapy at Janssen has used collaboration, creative thinking and pragmatism to create a CAR-T multiple myeloma breakthrough.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Carl Turner framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carl Turner
    Image attribution tooltip

    Disrupters: Carl Turner

    How Klick’s first-ever chief brand strategy officer is relying on collaboration to advance innovative strategies for clients and opportunities for people of color.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Julie Kim framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Julie Kim
    Image attribution tooltip

    Disrupters: Julie Kim

    The president of Takeda’s U.S. business unit and U.S. country head has steered through the pandemic, turning her aptitude for bringing people together into a master class in perseverance.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Carol Lynch framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carol Lynch
    Image attribution tooltip

    Legacy Leaders: Carol Lynch

    The chief business officer for Sandoz combines a shrewd business sense with a generous approach to leadership.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Karin Jooss framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Karin Jooss
    Image attribution tooltip

    Innovators: Karin Jooss

    The EVP and head of R&D at Gritstone bio is using her decades as a visionary drug developer to help the company advance vaccines for cancer.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Charlene Stern framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Charlene Stern
    Image attribution tooltip

    Disrupters: Charlene Stern

    How the chief lawyer of Editas Medicine is using a multi-lens approach to bolster the development of game-changing genomic medicines.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Kathy Lee-Sepsick framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kathy Lee-Sepsick
    Image attribution tooltip

    Entrepreneurs: Kathy Lee-Sepsick

    Kathy Lee-Sepsick, the founder of Femasys, is determined to change the game in long-neglected areas of women’s healthcare, some of which haven’t had much innovation in more than a century.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Chris Round framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Chris Round
    Image attribution tooltip

    Legacy Leaders: Chris Round

    The president of EMD Serono, the U.S. and Canadian healthcare business unit of Merck KGaA, Darmstadt, Germany, has the company firing on all cylinders for near- and long-term growth.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Kerry Blanchard framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Everest Medicines
    Image attribution tooltip

    Legacy Leaders: Dr. Kerry Blanchard

    The former CEO of Everest Medicines has focused on breaking new ground for China-based innovation.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Cristian Massacesi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Cristian Massacesi
    Image attribution tooltip

    Innovators: Dr. Cristian Massacesi

    With the goal of redefining how medicines are made, the CMO and oncology CDO is transforming AstraZeneca’s oncology development.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Kim Johnson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kim Johnson
    Image attribution tooltip

    Legacy Leaders: Kim Johnson

    The Global CEO is breathing fresh air into Ogilvy Health as she blazes a new trail at the storied agency.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Kuldeep Singh Rajput framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kuldeep Singh Rajput
    Image attribution tooltip

    Entrepreneurs: Kuldeep Singh Rajput

    Bringing digital solutions to Big Pharmas adapting to a more patient-centric age, the CEO and founder of Biofourmis has instituted a flexible approach that keeps its tech on the leading edge.

    Michael Gibney • Sept. 6, 2022
  • A portrait of David Katz framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by David Katz
    Image attribution tooltip

    Entrepreneurs: David Katz

    As the founder and chief scientific officer of Sparrow Pharmaceuticals, David Katz is breathing new life into drugs that have previously been shelved.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Kunal Ghosh framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kunal Ghosh
    Image attribution tooltip

    Tech Wizards: Kunal Ghosh

    The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Dawn Berry framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dawn Berry
    Image attribution tooltip

    Entrepreneurs: Dawn Barry

    The co-founder and president of LunaPBC is seeking to eliminate the middlemen in drug development by connecting patients — and their real-world data — directly with researchers.

    PharmaVoice staff • Sept. 6, 2022